Panacea products have not been fully utilised, says Mankind Pharma MD as IPO subscription opens

Mankind Pharma believes that it can exploit the potential of Panacea's product portfolio to create a more comprehensive and diverse offering to its customers. The company acquired Panacea Biotec Pharma's formulations brands in February 2022. Rajeev Juneja, VC and MD of Mankind Pharma said this as the company's IPO subscription opened on Monday.